PMID- 28838743 OWN - NLM STAT- MEDLINE DCOM- 20190109 LR - 20190109 IS - 1878-1780 (Electronic) IS - 1262-3636 (Linking) VI - 44 IP - 4 DP - 2018 Sep TI - Total serum bilirubin and 8-year incident type 2 diabetes mellitus: The Korean Genome and Epidemiology Study. PG - 346-353 LID - S1262-3636(17)30477-9 [pii] LID - 10.1016/j.diabet.2017.07.004 [doi] AB - AIM: In this study, the impact of serum bilirubin on new-onset type 2 diabetes mellitus (T2DM) in Korean adults was investigated. METHODS: Data were obtained from the Korean Genome and Epidemiology Study (KoGES), a population-based prospective cohort study. The study enrolled 8650 adults (4015 men and 4635 women), aged 40 to 69 years, who underwent a mean follow-up of 8.4 years. The study population was divided into quartiles (Q) of serum bilirubin levels, with cut-off points at 0.46, 0.61 and 0.82mg/dL for men, and 0.35, 0.47 and 0.61mg/dL for women. T2DM was defined based on the following data: fasting blood glucose>/=7.0mmol/L, HbA(1c) level>/=6.5% or 2-h plasma glucose>/=11.1mmol/L during a 75-g oral glucose tolerance test. RESULTS: Over the mean 8.4-year follow-up, 786 participants (9.1%) developed T2DM. Compared with Q1, the odds ratios (ORs) and 95% confidence intervals (CIs) for T2DM incidence were 0.52 (0.36-0.74) in men and 0.56 (0.38-0.83) in women aged >/=50 years, respectively, in the highest Q group after adjusting for possible confounding factors. These significant results persisted in those with impaired glucose tolerance and impaired fasting glucose. CONCLUSION: The results of this study reveal a protective role for serum total bilirubin on new-onset T2DM in Korean men and women. In addition, serum total bilirubin had favourable effects on new-onset T2DM in those with impaired glucose tolerance and impaired fasting glucose. CI - Copyright (c) 2017 Elsevier Masson SAS. All rights reserved. FAU - Kwon, Y-J AU - Kwon YJ AD - Department of Family Medicine, Yonsei University College of Medicine, Yong-in Severance Hospital, 225 Geumhakno, Cheoin-gu, Yongin-si, 17046 Gyeonggi-do, Republic of Korea; Department of Medicine, Graduate School of Yonsei University College of Medicine, Seoul, Republic of Korea. FAU - Lee, Y-J AU - Lee YJ AD - Department of Family Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. FAU - Park, B-J AU - Park BJ AD - Department of Family Medicine, Yonsei University College of Medicine, Yong-in Severance Hospital, 225 Geumhakno, Cheoin-gu, Yongin-si, 17046 Gyeonggi-do, Republic of Korea. FAU - Hong, K-W AU - Hong KW AD - TheragenEtex BioInstitue Co., Ltd., Suwon, Gyunggi, Republic of Korea. FAU - Jung, D-H AU - Jung DH AD - Department of Family Medicine, Yonsei University College of Medicine, Yong-in Severance Hospital, 225 Geumhakno, Cheoin-gu, Yongin-si, 17046 Gyeonggi-do, Republic of Korea. Electronic address: balsan2@yuhs.ac. LA - eng PT - Journal Article DEP - 20170831 PL - France TA - Diabetes Metab JT - Diabetes & metabolism JID - 9607599 RN - 0 (Blood Glucose) RN - RFM9X3LJ49 (Bilirubin) SB - IM MH - Adult MH - Aged MH - Bilirubin/*blood MH - Blood Glucose MH - Diabetes Mellitus, Type 2/*blood/*epidemiology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Prospective Studies MH - Republic of Korea/epidemiology OTO - NOTNLM OT - Bilirubin OT - Impaired fasting glucose OT - Impaired glucose tolerance OT - KoGES OT - Type 2 diabetes mellitus EDAT- 2017/08/26 06:00 MHDA- 2019/01/10 06:00 CRDT- 2017/08/26 06:00 PHST- 2017/04/10 00:00 [received] PHST- 2017/07/07 00:00 [revised] PHST- 2017/07/14 00:00 [accepted] PHST- 2017/08/26 06:00 [pubmed] PHST- 2019/01/10 06:00 [medline] PHST- 2017/08/26 06:00 [entrez] AID - S1262-3636(17)30477-9 [pii] AID - 10.1016/j.diabet.2017.07.004 [doi] PST - ppublish SO - Diabetes Metab. 2018 Sep;44(4):346-353. doi: 10.1016/j.diabet.2017.07.004. Epub 2017 Aug 31.